Insomnia
Conditions
Interventions
Buccal acupuncture adjunct group:Buccal acupuncture combined with basic therapy
Primary treatment group:Basic treatment
Sponsors
Chengdu Fifth People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Male or female aged 18~70 years old; (2) Insomnia Severity Index (ISI) >10 points); (3) Benzodiazepines (BZDs) were taken for 1 month > 1 month (continuous use during the 2 weeks before the test); (4) Willing to reduce benzodiazepines according to the protocol.
Exclusion criteria
Exclusion criteria: (1) Those who are unable to cooperate with the completion of treatment; (2) Heart failure, respiratory failure, liver and kidney insufficiency, malignant tumors and other serious systemic diseases; (3) Allergies or allergies to study drugs; (4) Apnea syndrome and other organic diseases; (5) Infection at the site of stellate ganglion block or buccal needle application, skin breakage, and history of obvious head and neck trauma; (6) Thrombocytopenia less than 50×10^9/L, coagulation dysfunction, taking anticoagulant drugs; (7) Those with mental disorders caused by alcohol abuse and drug abuse; (8) Patients who are pregnant or lactating; (9) Combined with schizophrenia, affective disorders, severe depression, neurosis, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cessation rate of BZDs(Benzodiazepines) after 4 weeks of treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cessation rate of BZDs(Benzodiazepines) after 12weeks of treatment;Equivalent dose and weekly frequency of diazepam;Reduced equivalent dose of sleep medicine;insomnia severity index;Hamilton Depression Scale;HamiltonAnxiety Scale;Self-rating scale of somatization symptoms;Epworth Sleepiness Scale;Quality of life scale(SF-12V2);BZDs Withdrawal Symptoms Questionnaire;Adverse reactions and complications; | — |
Countries
China
Contacts
Public ContactYin Hong
Chengdu Fifth People's Hospital
Outcome results
None listed